Precision BioSciences: Advancing Cancer Therapies Amid Biotech VolatilityPrecision BioSciences: biotech leader developing breakthrough cancer therapies, with volatile stock yet high investor interest and $194M market cap.PRECISION BIOSCIENCES INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 03/11/2026, 14:15 2 minutes to read